v3.25.2
Cover
 12 Months Ended
Mar. 31, 2025
shares
Document Information [Line Items]  
Document type 20-F
Document registration statement false
Document annual report true
Current fiscal year end date --03-31
Document period end date Mar. 31, 2025
Document transition report false
Document shell company report false
Entity file number 001-38757
Entity registrant name Takeda Pharmaceutical Company Limited
Entity incorporation, state or country code M0
Entity address, address line one 1-1, Nihonbashi-Honcho 2-Chome
Entity address, address line two Chuo-ku
Entity address, city or town Tokyo
Entity address, postal zip code 103-8668
Entity address, country JP
Entity well-known seasoned issuer Yes
Entity voluntary filers No
Entity current reporting status Yes
Entity interactive data current Yes
Entity filer category Large Accelerated Filer
Entity emerging growth company false
ICFR auditor attestation flag true
Document Financial Statement Error Correction [Flag] false
Document accounting standard International Financial Reporting Standards
Entity shell company false
Entity central index key 0001395064
Document fiscal year focus 2025
Document fiscal period focus FY
Amendment flag false
ADS  
Document Information [Line Items]  
Entity common stock, shares outstanding (in shares) 123,490,548
Ordinary shares  
Document Information [Line Items]  
Entity common stock, shares outstanding (in shares) 1,573,649,646
New York Stock Exchange | ADS  
Document Information [Line Items]  
Title of 12(b) security American Depositary Shares Representing Common Stock Common Stock, no par value
Trading symbol TAK
Security exchange name NYSE
New York Stock Exchange | Ordinary shares | 0.750% Senior Notes due 2027  
Document Information [Line Items]  
Title of 12(b) security 0.750% Senior Notes due 2027
Trading symbol TAK27
Security exchange name NYSE
New York Stock Exchange | Ordinary shares | 1.000% Senior Notes due 2029  
Document Information [Line Items]  
Title of 12(b) security 1.000% Senior Notes due 2029
Trading symbol TAK29
Security exchange name NYSE
New York Stock Exchange | Ordinary shares | 1.375% Senior Notes due 2032  
Document Information [Line Items]  
Title of 12(b) security 1.375% Senior Notes due 2032
Trading symbol TAK32
Security exchange name NYSE
New York Stock Exchange | Ordinary shares | 2.000% Senior Notes due 2040  
Document Information [Line Items]  
Title of 12(b) security 2.000% Senior Notes due 2040
Trading symbol TAK40A
Security exchange name NYSE
Business contact  
Document Information [Line Items]  
Entity address, address line one 1-1, Nihonbashi-Honcho 2-Chome
Entity address, address line two Chuo-ku
Entity address, city or town Tokyo
Entity address, postal zip code 103-8668
Entity address, country JP
Contact personnel name Milano Furuta
City area code +81
Local phone number 3 3278-2306
Contact personnel fax number +81 3 3278-2268
Contact personnel email address Global.External.Reporting@takeda.com